A key regulatory role of the transcription factor NFATc2 in bronchial adenocarcinoma via CD8+ T lymphocytes

Cancer Research

Volumn 69, Issue 7, 2009, Pages 3069-3076

  Maxeiner, Joachim H ^a   Karwot, Roman ^a   Sauer, Kerstin ^a   Scholtes, Petra ^a   Boross, Ildiko ^a   Koslowski, Michael ^b   Türeci, Özlem ^b   Wiewrodt, Rainer ^b   Neurath, Markus F ^a   Lehr, Hans A ^c   Finotto, Susetta ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Department of Internal Medicine III ^*

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; MESSENGER RNA; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 7 RECEPTOR, ALPHA CHAIN; INTERLEUKIN-7 RECEPTOR, ALPHA CHAIN; NERVE GROWTH FACTOR RECEPTOR; NFATC2 PROTEIN, HUMAN; TNFRSF18 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CELL TRANSFER; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; ADENOCARCINOMA; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BRONCHUS TUMOR; CD4+ T LYMPHOCYTE; DISEASE MODEL; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; METABOLISM; TRANSGENIC MOUSE; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; BRONCHIAL NEOPLASMS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; NFATC TRANSCRIPTION FACTORS; RECEPTORS, INTERLEUKIN-7; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA1; TRANSPLANTATION, HETEROLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 66149143198     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-1678     Document Type: Article

References (35)

1. Van Der Bruggen P, Zhang Y, Chaux P, et al. Tumor- spedflc shared antigenic peptides recognized by human T cells. Immunol Rev 2002;188:51-64.
2. Rosenberg SA1 Yang JC1 Restlfo NP. Cancer Immuno- therapy: moving beyond current vaccines. Nat Med 2004;10:909-915
3. Sakaguchi S. Naturally arising C.D4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004;22:531-562
4. Shimizu J, Yamazaki S, Sakaguchi S. Induction of tumor immunity by removing CD25+CD4+ T cells: a common, basis between tumor Immunity and autoim- munity. J Immunol 1999;163:5211-5218
5. Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, Nakayama E. Tumor rejection by in vivo administration of antl-CD25 (in.terleukin-2 receptor a) monoclonal antibody. Cancer Res 1999;59:3128-3133
6. Sutmuller RP, van Duivenvoorde LM, van Elsas A, et al. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 2001;194:823-832
7. Danke NA, Koelle DM, Yee C, Beheray S, Kwok WW. Autoreactive T cells in healthy individuals. J Immunol 2004;172:5967-5972
8. Peng SL, Gerth AJ, Ranger AM, Glimcher LH. NFATcI and NFATc2 together control both T and B cell activation, and differentiation. Immunity 2001;14:13-20.
9. Klein. M, Klein-Hessling S, Palmetshofer A, et al. Specific and redundant roles for NFAT transcription factors in the expression of mast cell-derived cytokines. J Immunol 2006;177:6667-6674
10. Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 1997;15:707-747
11. Hodge MR, Ranger AM, Charles de la Brousse F, Hoey T, Grusby MJ, Glimcher LH. Hyperproliferation and dysregulation of I.L-4 expression, in NF-ATp-defldent mice. Immunity 1996;4:397-405.
12. Dubinett SM1 Patrone L1 Tobias J1 Cochran AJ1 Wen DR1 McBride WH. Intratumoral in.terleukin-2 immuno- therapy: activation of tumor-infiltrating and splenic lymphocytes in vivo. Cancer Immunol Immunother 1993:36:156-162
13. Jassar AS1 Suzuki E1 Kapoor V1 et al. Activation of tumor-assodated macrophages by the vascular disrupt- ing agent 5,6-dimethylxanthenone-4-acetic acid, induces an effective C.D8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma Cancer Res 2005;65:11752-11761
14. Odaka M, Sterman DH, Wlewrodt R, et al. Eradication, of intraperitoneal and distant tumor by adenovirus-mediated interferon-ß gene therapy is attributable to induction of systemic immunity. Cancer Res 2001;61:6201-6212
15. Maxelner JH1 Karwot R1 Hausdlng M1 Sauer KA1 Scholtes P1 Flnotto S. A method to enable the investigation of murine bronchial immune cells, their cytokines and mediators. Nat Protocol 2007;2:105-112
16. Finotto S, Neurath MF, Glickman JN, et al Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 2002;295:336-338
17. Sauer KA, Scholtes P, Karwot R, Finotto S. Isolation of C.D4+ T cells from, murine lungs: a method to analyze on- going immune responses in the lung. Nat Protoč 2006:1: 2870-2875
18. Boehm U, Klamp T, Groot M Howard JC. Cellular re- sponses to interferon-γ. Annu Rev Immunol 1997;15:749-95.
19. Wigginton JM, Gruys E, Geiselhart L, et al. IFN-1V and Fas/FasL are required for the antitumor and antiangio- genic effects of IL-12/pulse IL-2 therapy. J Clin Invest 2001;108:51-62.
20. Teixeira LK, Fonseca BP, Vieira-de-Abreu A, et al. IFN- 1 production by CD8+ T cells depends on NFATl transcription factor and regulates Th differentiation. J Immunol 2005;175:5931-5939
21. Karwot R1 Maxelner JH1 Schmitt S1 et al. Protective role of nuclear factor of activated T cells 2 in CD8+ long- lived memory T cells in an allergy model. J Allergy Clin Immunol 2008;121:992-996
22. Akbar AN, Taams LS, Salmon M, Vukmanovic-Stejic M1 The peripheral generation of CD4+ CD25+ regulatory T cells. Immunology 2003;109:319-325
23. Golgher D1 Jones E1 Powrie F1 Elliott T1 Gallimore A. Depletion of CD25- regulatory cells uncovers immune responses to shared murine tumor rejection antigens. Eur J Immunol 2002;32:3267-3275
24. Tanaka H1 Tanaka J1 Kjaergaard J1 Shu S. Depletion of CD4+ C.D25+ regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodes. J Immunother 2002;25:207-217
25. Murakami M, Sakamoto A, Bender J, Kappler J, Marrack P. CD25+CD4+ T cells contribute to the control of memory CD8+ T cells. Proc Natl Acad Sci USA 2002; 99:8832-8837
26. McHugh RS1 Whltters MJ1 Piccirillo CA1 et al. CD4(+)CD25(+) immunoregulatory T cells: gene expres- sion analysis reveals a functional role for the glucocor- ticoid-induced TNF receptor. Immunity 2002;16:311-323
27. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self- tolerance. Nat Immunol 2002;3:135-142
28. Ko K1 Yamazaki S1 Nakamura K1 et al. Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regula- tory T cells. J Exp Med 2005;202:885-891
29. Codarri L, Vallotton L, Ciuffreda D1 et al. Expansion and tissue infiltration of an. allospeclfic CD4+C.D25+ CD45RO+IL-7Ra high cell population in solid organ transplant recipients. J Exp Med 2007:204:1533-41.
30. Seddon B1 Tomlinson P1 Zamoyska R. Interleukln 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat Immunol 2003;4:680-686
31. Kaminuma O1 Kitamura F1 Kitamura N1 et aL Differen- tial contribution of NFATc2 and NFATcI to TNF-ct gene expression in T cells. J Immunol 2008;180:319-326
32. Dooms H1 Wolslegel K1 Lin P1 Abbas AK. Interleukin-2 enhances CD4+ T cell memory by promoting the generation, of IL-7R a-expressing cells. J Exp Med 2007; 204:547-557
33. Vudattu NK1 Magalhaes I, Schmidt M1 Seyfert- Margolis V1 Maeurer MJ. Reduced numbers of IL-7 receptor (CD127) expressing immune cells and IL-7- signaling defects in peripheral blood from patients with breast cancer. Int J Cancer 2007;121:1512-1519
34. Dienz O, Eaton. SM, Krahl TJ, et al. Accumulation of NFAT mediates IL-2 expression in memory, but not naive, CD4+ T cells. Proc Natl Acad Sci USA 2007;104; 7175-7180
35. Cho JH, Boyman O, Kim HO, et al. An intense form of homeostatic proliferation of naive C.D8+ cells driven by IL-2. J Exp Med 2007;204:1787-1801